Skip to main content
. 2011 Mar;178(3):1340–1349. doi: 10.1016/j.ajpath.2010.11.058

Table 2.

Kinase Activation in Response to CXCL5 in HUVECs

Phospho-Kinase % increase P value
Akt (S473) 24.7 0.06
Akt (T308) 25.82 0.1
TOR 74.9 0.01
GSK (3α/β) 20.5 0.07
p70 S6 kinase (T389) 37.1 0.1
p70 S6 kinase (T229) 51.7 0.03
p70 S6 kinase 31.1 0.05
ERK1/2 44.3 0.007
MEK1/2 34.0 0.01
p38α 16.2 0.3
JNK pan 21.3 0.001
RSK 1/2 36.5 0.002
RSK 1/2/3 28.9 0.03
FAK 47.8 0.08
β-catenin 20.5 0.003
Paxillin 27.5 0.1
Pyk-2 31.0 0.01
Src 59.4 0.002
Fyn 38.0 0.01
Lyn 43.8 0.05
Yes 35.1 0.02
Lck 39.7 0.001
Hck 38.2 0.02
JNK pan 21.3 0.1
STAT1 60.1 0.007
STAT2 36.3 0.01
STAT3 43.5 0.0001
STAT4 51.1 0.007
STAT5a 30.5 0.001
STAT5a/b 61.3 0.01
STAT5b 43.8 0.005
STAT6 46.4 0.01
p53 (S15) 14.0 0.004
p53 (S392) 10.1 0.01
p53 (S46) 10.8 0.003
p27 (T157) 29.7 0.01
P27 (T198) 33.5 0.02
CHK2 40.3 0.005
C-Jun 6.3 0.03
CREB 34.0 0.006
eNOS 3.06 0.09
HSP27 36.4 0.03
AMPKα1 22.7 0.01
AMPKα2 31.4 0.08
MSK1/2 24.1 0.01
PLCg-1 29.9 0.03

Cell lysate from CXCL5-treated (0.5 ng/ml) HUVECs were used for phospho-kinase array.